Troponin I in Patients without Chest Pain
Open Access
- 1 January 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (1), 112-119
- https://doi.org/10.1373/clinchem.2003.016311
Abstract
Background: Testing for troponin has important clinical value for patients who present with typical symptoms of acute coronary syndromes (ACS) such as chest pain (CP). Much less is known about the value of troponin testing for patients who present with other symptoms of ACS (anginal equivalent symptoms). Methods: The utilization and prognostic value of cardiac troponin I (cTnI) were evaluated at a Veterans Affairs Acute Care Facility. Clinical charts of 1184 predominantly male patients, who submitted specimens for initial cTnI testing by AxSYM, were evaluated for demographic data, cardiovascular risk factors, major diseases, and complaints at the time of testing. The endpoint was defined as all-cause death during a 200-day period after initial testing. Results: Sixty-one percent of cTnI tests were ordered for patients who did not present with CP. Patients presenting with symptoms other than CP did not have significantly lower plasma cTnI than patients with CP. However, patients with symptoms other than CP were rarely diagnosed with ACS unless cTnI was ≥2 μg/L. The mortality during the follow-up period was severalfold higher among patients presenting with symptoms other than CP (CP, 6%; without CP, 22%; P <0.0001, χ2 test). cTnI ≥0.2 μg/L provided significant additional predictive information for patients who presented with anginal equivalent symptoms such as shortness of breath or general weakness. Conclusion: Patients with anginal equivalent symptoms of ACS and low-positive cTnI are less often diagnosed with ACS and have a higher mortality than patients with CP.Keywords
This publication has 20 references indexed in Scilit:
- European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trialsAmerican Heart Journal, 2002
- Clinical Significance of Low-Positive Troponin I by AxSYM and ACS:180American Journal of Clinical Pathology, 2001
- The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysisJournal of the American College of Cardiology, 2001
- The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexesClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective studyIntensive Care Medicine, 2000
- Unstable Angina PectorisNew England Journal of Medicine, 2000
- 2001 — A biomarker odysseyClinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysisNephrology Dialysis Transplantation, 1999
- Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T LevelsNew England Journal of Medicine, 1999
- Cardiac troponin I. A marker with high specificity for cardiac injury.Circulation, 1993